Company Filing History:
Years Active: 2006-2010
Title: Elizabeth Doorly Graham: Innovator in Phosphodiesterase Inhibitors
Introduction
Elizabeth Doorly Graham is a notable inventor based in River Vale, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of phosphodiesterase 4 inhibitors. With a total of 2 patents to her name, her work has the potential to impact various therapeutic areas.
Latest Patents
Graham's latest patents focus on phosphodiesterase 4 inhibition achieved through novel nitroxide compounds. These include N-substituted aniline and diphenylamine analogs. The compounds of her invention are represented by specific formulas, wherein A, B, D, R, and other variables are defined in detail. This innovative approach to PDE4 inhibition showcases her expertise and commitment to advancing medical science.
Career Highlights
Throughout her career, Elizabeth has been associated with Memory Pharmaceuticals Corporation, where she has been instrumental in research and development. Her work has contributed to the understanding and potential treatment of various conditions through the modulation of phosphodiesterase enzymes.
Collaborations
Graham has collaborated with notable colleagues, including Richard A Schumacher and Allen T Hopper. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Elizabeth Doorly Graham stands out as a pioneering inventor in the field of phosphodiesterase inhibitors. Her contributions through her patents and collaborations reflect her dedication to advancing pharmaceutical science.